FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab ® HEK293 HCP Type SN ...

Cell culture media specialized for gene therapy production are uniquely designed to support the growth, viability, and productivity of cells used to manufacture gene therapy products, such as viral ...

FUJIFILM Biosciences, announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 ...